{"id":"W4383058531","doi":"10.1002/ueg2.12436","title":"Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?","year":2023,"lang":"en","type":"editorial","venue":"United European Gastroenterology Journal","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Genentech; Novo Nordisk; AstraZeneca; UCB Pharma; Pfizer","keywords":"Medicine; Disease; Ulcerative colitis; Mesalazine; Internal medicine; Gastroenterology; Clinical trial; Inflammatory bowel disease; Clinical endpoint; Retrospective cohort study; Quality of life (healthcare); Psoriasis; Post-hoc analysis; Surgery; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007991842,0.0006280745,0.004437596,0.0008407487,0.0007031052,0.004005902,0.001070007,0.002756787,0.002900947],"category_scores_gemma":[0.01441267,0.0002520319,0.0007681685,0.001171352,0.003145748,0.005713237,0.001342208,0.005266785,0.001215984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001516841,"about_ca_system_score_gemma":0.001423808,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008901164,"about_ca_topic_score_gemma":0.0008118408,"domain_scores_codex":[0.9956554,0.002134467,0.000535148,0.0004262356,0.001001237,0.0002473977],"domain_scores_gemma":[0.9893996,0.005946723,0.001696236,0.0004411126,0.00176219,0.0007539627],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00284302,0.0004485114,0.00758576,0.007643714,0.0004631113,0.0004822223,0.0004904399,0.0004765633,0.001999856,0.02301529,0.06097763,0.8935739],"study_design_scores_gemma":[0.001517627,0.008293124,0.04185034,0.02751201,0.001706786,0.00757763,0.002206752,0.003425183,0.003663209,0.1457301,0.7560964,0.0004208898],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.004746318,0.9129571,0.001902399,0.07611887,0.002038872,0.00002210393,0.00006732339,0.00004071556,0.002106251],"genre_scores_gemma":[0.1690104,0.7424824,0.003548212,0.04934667,0.03263841,0.0001039722,0.0002772399,0.00008140043,0.002511291],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.007991842,"threshold_uncertainty_score":0.04226536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007845484166055438,"score_gpt":0.2431171967631602,"score_spread":0.2352717125971047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}